<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-141745" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Iridocorneal Endothelial Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Das</surname>
            <given-names>Shibandri</given-names>
          </name>
          <aff>Kresge Eye Institute/Wayne State University School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tur</surname>
            <given-names>Komalpreet</given-names>
          </name>
          <aff>WSUSOM</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tripathy</surname>
            <given-names>Koushik</given-names>
          </name>
          <aff>ASG Eye Hospital, BT Road, Kolkata, India</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Shibandri Das declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Komalpreet Tur declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Koushik Tripathy declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>25</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-141745.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Iridocorneal endothelial syndrome (ICE) is a rare condition characterized by the increased proliferation and migration of corneal endothelial cells to the iris and iridocorneal angle, leading to secondary angle-closure glaucoma, corneal edema, and atrophy of the iris. ICE is a group of disorders with three clinically distinct variants, including essential iris atrophy (EIA), Chandler syndrome (CS), and Cogan-Reese syndrome (CRS). If left untreated, each variant may progress to blindness. However, prompt diagnosis and multidisciplinary management can mitigate this catastrophic outcome. This activity reviews the pathophysiology, signs and symptoms, evaluation, differential diagnosis, and management of ICE and highlights the role of the interprofessional team in evaluating and treating patients with this rare condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify patients who would benefit from prompt evaluation for iridocorneal epithelial syndrome based on clinical presentation.</p></list-item><list-item><p>Apply the pathophysiologic processes of iridocorneal epithelial syndrome to the development of common complications.</p></list-item><list-item><p>Employ best practices when treating patients with iridocorneal syndrome.</p></list-item><list-item><p>Develop and effectively implement interprofessional team processes to improve outcomes for patients with iridocorneal syndrome.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=141745&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=141745">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-141745.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Iridocorneal endothelial syndrome (ICE) is a rare disorder characterized by the increased proliferation and migration of corneal endothelial cells to the iris and iridocorneal angle, leading to secondary angle-closure glaucoma, corneal edema, and atrophy of the iris.<xref ref-type="bibr" rid="article-141745.r1">[1]</xref>&#x000a0;This condition is often associated with secondary glaucoma due to obstruction of the trabecular meshwork in the iridocorneal angle, the formation of peripheral anterior synechiae of the iris, or both.<xref ref-type="bibr" rid="article-141745.r1">[1]</xref>&#x000a0;Patients typically present with changes in the shape of the iris, a decrease in visual acuity, blurred vision, or a combination thereof.<xref ref-type="bibr" rid="article-141745.r2">[2]</xref>&#x000a0;Vision loss typically occurs due to the progression of secondary glaucoma and corneal decompensation.<xref ref-type="bibr" rid="article-141745.r3">[3]</xref>&#x000a0;If left untreated, ICE can progress to blindness.<xref ref-type="bibr" rid="article-141745.r4">[4]</xref>&#x000a0;</p>
        <p>ICE is typically a unilateral disorder and more frequently affects young adults and middle-aged females.<xref ref-type="bibr" rid="article-141745.r5">[5]</xref><xref ref-type="bibr" rid="article-141745.r6">[6]</xref>&#x000a0;The 3 clinical variants of ICE are essential iris atrophy (EIA), Chandler syndrome (CS), and Cogan-Reese syndrome (CRS).<xref ref-type="bibr" rid="article-141745.r1">[1]</xref><xref ref-type="bibr" rid="article-141745.r2">[2]</xref>&#x000a0;The clinical features of&#x000a0;EIA include&#x000a0;iridic changes such as full-thickness holes and endothelial dystrophy (see <bold>Image.&#x000a0;</bold>Iridocorneal Endothelial Syndrome: Essential Endothelial Syndrome).<xref ref-type="bibr" rid="article-141745.r1">[1]</xref>&#x000a0;The most common variant of ICE is CS, characterized by less iridic involvement, unilateral visual impairment, iridic atrophy, corectopia, and significantly more corneal edema, epithelial bullae, and endothelial dystrophy.<xref ref-type="bibr" rid="article-141745.r1">[1]</xref>&#x000a0;The&#x000a0;CRS typically presents with nodules on the anterior surface of the iris and&#x000a0;perhaps endothelial&#x000a0;disease and corneal edema.<xref ref-type="bibr" rid="article-141745.r1">[1]</xref><xref ref-type="bibr" rid="article-141745.r2">[2]</xref></p>
      </sec>
      <sec id="article-141745.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The pathogenesis of ICE is not fully understood; several working hypotheses exist. Corneal endothelial cells are postmitotic and typically do not proliferate in vivo; the quantity of these cells&#x000a0;decreases with age.<xref ref-type="bibr" rid="article-141745.r7">[7]</xref><xref ref-type="bibr" rid="article-141745.r8">[8]</xref>&#x000a0;ICE can develop when corneal endothelial cells regain proliferative capacity.<xref ref-type="bibr" rid="article-141745.r3">[3]</xref>&#x000a0;Corneal endothelial cells play an important role in regulating corneal hydration and transparency, and&#x000a0;endothelial dysfunction leads to corneal edema and visual defects.<xref ref-type="bibr" rid="article-141745.r9">[9]</xref>&#x000a0;</p>
        <p>The neural crest theory is one proposed pathogenic mechanism for ICE development.&#x000a0;This theory stratifies different ocular endothelial disorders by neural crest origin. ICE was thought to be related to abnormal neural crest cell (NCC) proliferation, compared to NCC formation in cyclopia, NCC migration in Peters anomaly, or NCC differentiation in Fuchs dystrophy.<xref ref-type="bibr" rid="article-141745.r10">[10]</xref></p>
        <p>In Peters anomaly, an abnormality in the development of the first wave of neural crest cells&#x000a0;leads to a failure of separation between lens vesicles and surface ectoderm,&#x000a0;causing corneal opacification.<xref ref-type="bibr" rid="article-141745.r11">[11]</xref><xref ref-type="bibr" rid="article-141745.r12">[12]</xref><xref ref-type="bibr" rid="article-141745.r13">[13]</xref>&#x000a0;Type 1 Peters anomaly&#x000a0;is characterized by iridocorneal adhesions,&#x000a0;the development of corneal opacity, and a striking similarity to ICE.<xref ref-type="bibr" rid="article-141745.r14">[14]</xref><xref ref-type="bibr" rid="article-141745.r15">[15]</xref><xref ref-type="bibr" rid="article-141745.r16">[16]</xref> However, compared with ICE, Peters anomaly presents at a younger age and occurs bilaterally in 80% of cases.<xref ref-type="bibr" rid="article-141745.r17">[17]</xref> Fuchs dystrophy is also a bilateral endothelial disorder, but unlike Peters anomaly and ICE, it does not present with iridocorneal adhesions.<xref ref-type="bibr" rid="article-141745.r1">[1]</xref> Similar to ICE, Fuchs dystrophy may present with corneal edema.<xref ref-type="bibr" rid="article-141745.r18">[18]</xref>&#x000a0;</p>
        <p>Cambell, Shields, and Smith proposed their membrane theory in 1978 to better explain the corneal endothelial structural changes and abnormalities associated with ICE.<xref ref-type="bibr" rid="article-141745.r19">[19]</xref>&#x000a0;The membrane theory characterizes&#x000a0;ICE as primary proliferative endothelial degeneration&#x000a0;and emphasizes that this disease is primarily corneal in origin with secondary impacts on the iris. According to the membrane theory, the initial pathologic insult involves corneal endothelial degeneration that progresses to abnormal endothelial membrane overgrowth around the iridocorneal angle. Obstruction of the trabecular meshwork and contraction of the membrane leads to structural changes in the iris, secondary glaucoma, and ectropion uveae.<xref ref-type="bibr" rid="article-141745.r20">[20]</xref>&#x000a0;Further histological studies of ICE cell characteristics have supported the membrane theory.<xref ref-type="bibr" rid="article-141745.r19">[19]</xref><xref ref-type="bibr" rid="article-141745.r21">[21]</xref></p>
        <p>Although these&#x000a0;hypotheses discuss the progression of ICE, the causal&#x000a0;factor&#x000a0;of ICE remains undetermined.&#x000a0;Various studies have described an&#x000a0;association between ICE and inflammation or uveitis.<xref ref-type="bibr" rid="article-141745.r1">[1]</xref>&#x000a0;Another proposed&#x000a0;pathogenic mechanism points to a viral trigger. In 1994, Alvarado&#x000a0;et al investigated ICE's potential viral etiology using polymerase chain reaction and identified Herpes simplex viral (HSV) DNA in &#x0003e;60% of tested ICE specimens.<xref ref-type="bibr" rid="article-141745.r22">[22]</xref>&#x000a0;In this study, corneal control specimens consisted of normal corneas and corneas with keratoconus, interstitial keratitis, or aphakic bullous keratopathy. None of the control corneas&#x000a0;tested positive for HSV DNA. Interestingly, when the corneal endothelial layer was removed from ICE specimens, HSV DNA was no longer detected. This finding provided direct evidence to support the idea that viral DNA was confined to the endothelial cell layer.<xref ref-type="bibr" rid="article-141745.r1">[1]</xref><xref ref-type="bibr" rid="article-141745.r22">[22]</xref>&#x000a0;Other studies report an association between Epstein-Barr virus (EBV) and ICE.<xref ref-type="bibr" rid="article-141745.r23">[23]</xref></p>
      </sec>
      <sec id="article-141745.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>ICE is an acquired syndrome that typically presents unilaterally and predominantly affects females between the age of 20 and 50.<xref ref-type="bibr" rid="article-141745.r5">[5]</xref>&#x000a0;However, there are case reports of bilateral presentation, and ICE has been diagnosed in male patients.<xref ref-type="bibr" rid="article-141745.r24">[24]</xref>&#x000a0;Despite reports of concurrent ICE and sensorineural hearing loss, no definitive association has been established.&#x000a0;</p>
        <p>Observational studies indicate varying incidences of ICE subtypes among racial and ethnic groups. For instance, CS is the most common variant of ICE diagnosed&#x000a0;in White patients.<xref ref-type="bibr" rid="article-141745.r1">[1]</xref>&#x000a0;In contrast,&#x000a0;CRS&#x000a0;is the least frequently reported subtype in India at 14.29%, and&#x000a0;EIA has the highest incidence at 66.67%.<xref ref-type="bibr" rid="article-141745.r25">[25]</xref>&#x000a0;This study also documented the incidence of ICE in Indian male patients at 62%, compared with studies from North America and Europe, which reported the incidence in males as 17%.<xref ref-type="bibr" rid="article-141745.r26">[26]</xref></p>
      </sec>
      <sec id="article-141745.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathophysiology of ICE results from the increased proliferation and migration of corneal endothelial cells to the iridocorneal angle and iris, leading to secondary angle-closure glaucoma (see <bold>Image.</bold> Iridocorneal Endothelial Syndrome: Secondary Angle-Closure Glaucoma), corneal edema, and iridic atrophy.<xref ref-type="bibr" rid="article-141745.r1">[1]</xref></p>
      </sec>
      <sec id="article-141745.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>The cornea comprises multiple highly organized layers that maintain corneal transparency and barrier function. The nonproliferative layer of corneal endothelial cells is a barrier and a pump, helping to maintain the clarity and transparency of the cornea.<xref ref-type="bibr" rid="article-141745.r27">[27]</xref>&#x000a0;The corneal epithelial cells in patients with ICE are typically taller, and the multilayer organization is abnormal. These abnormal endothelial cells retain the microvilli or their normal counterparts.<xref ref-type="bibr" rid="article-141745.r1">[1]</xref>&#x000a0;</p>
        <p>Corneal decompensation occurs when persistent corneal insults lead to increasing corneal opacity.<xref ref-type="bibr" rid="article-141745.r28">[28]</xref>&#x000a0;The development of secondary glaucoma&#x000a0;is due to the formation of&#x000a0;peripheral anterior synechiae (PAS) or the growth of abnormal endothelial cells over the trabecular meshwork.<xref ref-type="bibr" rid="article-141745.r1">[1]</xref>&#x000a0;These histological changes lead to elevated intraocular pressure (IOP), the characteristic finding of glaucoma.<xref ref-type="bibr" rid="article-141745.r1">[1]</xref></p>
      </sec>
      <sec id="article-141745.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The typical presenting clinical symptoms of patients with ICE include changes in the shape of their pupil due to atrophy of the iris and visual changes such as decreased vision upon waking or blurred halo of lights due to corneal edema and subsequent corneal decompensation.<xref ref-type="bibr" rid="article-141745.r1">[1]</xref>&#x000a0;Patients may also develop ocular pain or headache if they have a severe increase in&#x000a0;IOP due to secondary glaucoma.<xref ref-type="bibr" rid="article-141745.r29">[29]</xref></p>
        <p>The external appearance of the affected eye is abnormal in patients with ICE but will vary with the stage of the disease and clinical variant.<xref ref-type="bibr" rid="article-141745.r1">[1]</xref>&#x000a0;The atrophic iridic changes characteristic of EIA may not be seen without careful slit-lamp examination.<xref ref-type="bibr" rid="article-141745.r1">[1]</xref>&#x000a0;Due to extensive endothelial dystrophy, patients with CS or CRS may develop significantly increased IOP, severe glaucoma, and corneal edema, which grossly appears as corneal opacification.<xref ref-type="bibr" rid="article-141745.r1">[1]</xref></p>
        <p>Ophthalmic examination of the corneal endothelium&#x000a0;may reveal &#x0201c;hammered silver&#x0201d; or &#x0201c;beaten bronze&#x0201d; irregularities during slit-lamp examination, a reversal light pattern during specular microscopy, or changes in the iridocorneal angle on gonioscopy. (see <bold>Image.</bold> Iridocorneal Endothelial Syndrome: Corneal Endothelium Irregularities). Cupping of the optic nerve may be seen in patients with secondary glaucoma).<xref ref-type="bibr" rid="article-141745.r30">[30]</xref></p>
        <p>A thorough physical examination includes a slit-lamp examination, a careful exam of the angle with gonioscopy, and tonometry or applanation. Techniques such as specular microscopy and in vivo corneal confocal microscopy (IVCM) can reveal pathognomonic findings.<xref ref-type="bibr" rid="article-141745.r1">[1]</xref><xref ref-type="bibr" rid="article-141745.r2">[2]</xref></p>
      </sec>
      <sec id="article-141745.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Early diagnosis of ICE is essential to prevent the complications of corneal edema and secondary glaucoma.<xref ref-type="bibr" rid="article-141745.r2">[2]</xref> If significant corneal edema prevents clear visualization of the anterior chamber structures, IVCM can be employed.</p>
        <p>IVCM is a noninvasive imaging technique that allows visualization of corneal layers at the cellular level. The abnormal corneal epithelial cells of patients with ICE appear as epithelial-like endothelial cells varying in size and shape, with bright cell borders and hyperreflective nuclei.<xref ref-type="bibr" rid="article-141745.r26">[26]</xref>&#x000a0;Specular microscopy is another imaging tool to evaluate the corneal epithelium; epithelial cells in patients with ICE are characterized by an abnormally large and round shape and display a pattern of "light-dark reversal." These abnormally dark cells&#x000a0;have&#x000a0;a light central spot with light borders, which is the opposite of normal endothelial cell light patterns. In addition to IVCM and specular microscopy, gonioscopy is required to visualize the iridocorneal angle. In ICE, there are often progressive broad-based synechiae located on the iris and around the trabecular meshwork.&#x000a0;</p>
        <p>If gonioscopy is&#x000a0;challenging due to corneal edema, ultrasound biomicroscopy can be used to visualize the anterior chamber angle and detect abnormalities.<xref ref-type="bibr" rid="article-141745.r31">[31]</xref>&#x000a0;Gonioscopy, in combination with ultrasound biomicroscopy, can be used to assess the size and extent of PAS fully.<xref ref-type="bibr" rid="article-141745.r2">[2]</xref></p>
        <p>Patients with ICE and subsequent secondary glaucoma should be evaluated with Humphrey visual field testing,&#x000a0;central corneal thickness measurements, intraocular pressure evaluation with Goldmann applanation tonometry, evaluation of the iridocorneal angle and trabecular meshwork with gonioscopy, optic nerve evaluation on physical examination, as well as optical coherence tomography of the optic nerve head and retinal nerve fiber layer.<xref ref-type="bibr" rid="article-141745.r32">[32]</xref><xref ref-type="bibr" rid="article-141745.r33">[33]</xref></p>
      </sec>
      <sec id="article-141745.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The treatment of ICE is typically centered around managing corneal decompensation and preventing irreversible glaucomatous vision loss. Surgical procedures may address iridic changes to improve cosmesis or vision-impacting defects.<xref ref-type="bibr" rid="article-141745.r1">[1]</xref>&#x000a0;</p>
        <p>Endothelial keratoplasty techniques such as Descemet stripping automated endothelial keratoplasty (DSAEK) and Descemet membrane endothelial keratoplasty (DMEK) are preferred over penetrating keratoplasty (PK) for the treatment of ICE-related corneal edema.<xref ref-type="bibr" rid="article-141745.r1">[1]</xref> DMEK improves outcomes and shortens recovery time when compared to DSAEK.<xref ref-type="bibr" rid="article-141745.r34">[34]</xref> A recent study evaluating the effectiveness of DMEK in patients with ICE showed an 85.7% cumulative graft success rate after 1 year.<xref ref-type="bibr" rid="article-141745.r34">[34]</xref>&#x000a0;However, DSAEK is the preferred procedure for patients with significant iris changes or copious synechiae.&#x000a0;If patients have failed multiple keratoplasty procedures, keratoprosthesis may be considered.<xref ref-type="bibr" rid="article-141745.r35">[35]</xref>&#x000a0;</p>
        <p>ICE damages&#x000a0;the functionality of the trabecular meshwork in the iridocorneal angle, blocking aqueous outflow and causing secondary glaucoma. Therefore,&#x000a0;topical eyedrops that decrease aqueous humor production are&#x000a0;preferred over those that increase trabecular aqueous outflow.<xref ref-type="bibr" rid="article-141745.r1">[1]</xref>&#x000a0;The primary treatment regimen for secondary glaucoma&#x000a0;includes topical beta blockers, carbonic anhydrase inhibitors, and alpha agonists. Topical prostaglandins have been associated with intraocular reactivation of HSV and should be avoided in patients with ICE.<xref ref-type="bibr" rid="article-141745.r1">[1]</xref><xref ref-type="bibr" rid="article-141745.r36">[36]</xref>&#x000a0;</p>
        <p>ICE-induced secondary glaucoma may be very challenging to control. If&#x000a0;IOP is not adequately&#x000a0;controlled&#x000a0;with topical ophthalmic medications, surgical&#x000a0;interventions such as goniotomy, trabeculectomy with antifibrotic agents such as mitomycin-C or 5-fluorouracil, glaucoma drainage implants, or cyclodestructive procedures must be considered.</p>
        <p>Goniotomy is an excellent surgical option to&#x000a0;relieve the obstruction to aqueous outflow caused by the ICE membrane over the angle.<xref ref-type="bibr" rid="article-141745.r37">[37]</xref> However, a new membrane can subsequently form over the goniotomy site resulting in recurrent obstruction.&#x000a0;Trabeculectomy with antimetabolites can be&#x000a0;performed to manage IOP&#x000a0;but usually fails over time due to&#x000a0;the proliferation of the endothelial membrane in the trabecular meshwork, ostium, and fistula, and the deposition of abnormal basement membrane within the bleb.<xref ref-type="bibr" rid="article-141745.r38">[38]</xref>&#x000a0;</p>
        <p>Trabeculectomy outcomes in patients with ICE are typically worse than in other disease processes, such as primary open-angle glaucoma, pigmentary glaucoma, and juvenile open-angle glaucoma.<xref ref-type="bibr" rid="article-141745.r39">[39]</xref><xref ref-type="bibr" rid="article-141745.r40">[40]</xref>&#x000a0;Success rates for patients with ICE are higher when&#x000a0;trabeculectomy is performed&#x000a0;early in the disease process.<xref ref-type="bibr" rid="article-141745.r41">[41]</xref>&#x000a0;In general, the success rate of trabeculectomy is approximately 60% at 1 year and 40% at 2 years.<xref ref-type="bibr" rid="article-141745.r42">[42]</xref>&#x000a0;</p>
        <p>Trabeculectomy with antimetabolites and glaucoma drainage implants offer postoperative IOP reduction for patients with ICE syndrome. Still, the long-term failure rate for trabeculectomy may be higher than for glaucoma drainage devices.<xref ref-type="bibr" rid="article-141745.r43">[43]</xref>&#x000a0;Glaucoma drainage devices may fail if the continued proliferation of the endothelial membrane blocks the drainage tube. Inserting the tube behind the iris at the ciliary sulcus, especially in pseudophakic eyes, may avoid this phenomenon.<xref ref-type="bibr" rid="article-141745.r1">[1]</xref>&#x000a0;Nd:YAG laser may be employed to reopen blocked drainage tubes due to endothelial proliferation.</p>
        <p>Cyclodestructive procedures may be employed when surgical interventions fail to control the IOP, resulting in a painful blind eye. The options for cyclodestructive procedures include diode laser cyclophotocoagulation, cyclocryotherapy, and endocyclophotocoagulation.&#x000a0;</p>
        <p>Femtosecond-assisted keratopigmentation (KTP) has shown promising results in eliminating the diplopia and photophobia common in patients with ICE.<xref ref-type="bibr" rid="article-141745.r44">[44]</xref>&#x000a0;Alternatively, multiple endocapsular iris prosthesis devices can be implanted inside the capsular bag in front of the intraocular lens to address iris atrophy&#x000a0;and photophobia and improve cosmesis.<xref ref-type="bibr" rid="article-141745.r1">[1]</xref><xref ref-type="bibr" rid="article-141745.r45">[45]</xref></p>
      </sec>
      <sec id="article-141745.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>ICE should be considered a potential diagnosis in any young&#x000a0;female with unilateral corneal edema, visual disturbances, iris abnormalities, or glaucoma.<xref ref-type="bibr" rid="article-141745.r2">[2]</xref>&#x000a0;The variants of ICE may present similarly to other disease processes, and it is essential to obtain a comprehensive medical history and perform a thorough physical examination to identify the correct underlying disease.</p>
        <p>The differential diagnosis for&#x000a0;CS includes posterior polymorphous corneal dystrophy (PPCD) and Fuchs endothelial dystrophy. PPCD is a corneal disorder that is typically bilateral and inherited in an autosomal dominant fashion. Similar to the ICE variants, patients with PPCD have areas of PAS that increase their risk for secondary glaucoma. However, the Descemet membrane of patients with PPCD is thickened and may&#x000a0;reveal vesicular, band-like, or diffuse opacities; the Descemet membrane in CS is normal. Fuchs endothelial dystrophy is a bilateral disorder and does not present with iridocorneal abnormalities, and IVCM reveals hyporeflective nuclei compared to the hyperreflective nuclei seen in ICE. Fuchs endothelial dystrophy often presents with endothelial guttae, or the deposition of an extracellular collagen-like matrix, in addition to corneal edema.<xref ref-type="bibr" rid="article-141745.r1">[1]</xref><xref ref-type="bibr" rid="article-141745.r18">[18]</xref></p>
        <p>The differential diagnosis for&#x000a0;EIA includes Axenfeld-Rieger syndrome (ARS), aniridia, and iridoschisis.<xref ref-type="bibr" rid="article-141745.r46">[46]</xref><xref ref-type="bibr" rid="article-141745.r47">[47]</xref><xref ref-type="bibr" rid="article-141745.r13">[13]</xref> ARS is a congenital disorder usually inherited in an autosomal dominant fashion but can occur sporadically. Patients with ARS display changes at birth and may have associated anomalies such as abnormal teeth. ARS is typically a bilateral disease, whereas ICE is usually unilateral. ICE and ARS display a similar pattern of an endothelial cell monolayer extending over the cornea, iridocorneal angle, and iris. However, since ARS is a congenital disorder, it is hypothesized that the iridocorneal membrane is due to the retention of primordial endothelium. A distinct differentiating factor between ARS and ICE is the posterior embryotoxon with iris strands of ARS.&#x000a0;</p>
        <p>Aniridia is another congenital disorder that is typically bilateral and often associated with other conditions, such as optic nerve hypoplasia. The age of onset can be an important factor in helping differentiate aniridia from late-stage EIA. Most cases of aniridia present within the first 6 weeks of life; other associated sensory deficits, such as hearing loss and decreased sense of smell, are common.<xref ref-type="bibr" rid="article-141745.r48">[48]</xref>&#x000a0;Iridoschisis is the progressive separation of the layers of the iris, is frequently bilateral, and most often occurs in older patients.<xref ref-type="bibr" rid="article-141745.r1">[1]</xref></p>
        <p>The differential diagnosis of CRS is broad and includes Tapioca melanoma and diffuse malignant melanoma of the iris. Tapioca melanoma presents with nodules on the iris similar to those in CRS. However, these nodules are typically hypopigmented compared to the hyperpigmented nodules in CRS. In addition, typical features of CRS, including PAS and iris atrophy, are not present in Tapioca melanoma. Diffuse malignant melanoma of the iris typically does not present with distortion of the pupillary margin and PAS, which are more suggestive of CRS.<xref ref-type="bibr" rid="article-141745.r1">[1]</xref></p>
      </sec>
      <sec id="article-141745.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of ICE is dependent on how advanced the disease is at the time of diagnosis and the presence of secondary complications. Corneal surgeries may not be able to excise the abnormal endothelium entirely and, therefore, may not prevent the progression of PAS and the development of secondary glaucoma.<xref ref-type="bibr" rid="article-141745.r2">[2]</xref>&#x000a0;</p>
        <p>A small case series of&#x000a0;8 eyes in 7 patients studied the outcome of DMEK in patients with both ICE and PPCD. This 2018 case series reported a statistically significant increase in best-corrected visual acuity in all eyes at 6 and 24 months following the procedures.<xref ref-type="bibr" rid="article-141745.r49">[49]</xref>&#x000a0;A more extensive study in 2020 analyzed 86 patients undergoing their first corneal transplants for ICE syndrome and the 5-year graft survival rates in patients who underwent penetrating keratoplasty (PKP) or endothelial keratoplasty (EK). There was no significant difference between corneal graft survival rates for PKP or EK procedures, with 64.3% and 66.8% survival rates, respectively.<xref ref-type="bibr" rid="article-141745.r50">[50]</xref></p>
      </sec>
      <sec id="article-141745.s12" sec-type="Complications">
        <title>Complications</title>
        <p>The complications of ICE include iris abnormalities, corneal edema and decompensation, and secondary glaucoma.<xref ref-type="bibr" rid="article-141745.r2">[2]</xref>&#x000a0;Glaucoma occurs in approximately 50% of patients with ICE and is more common in the EIA variant.<xref ref-type="bibr" rid="article-141745.r29">[29]</xref><xref ref-type="bibr" rid="article-141745.r37">[37]</xref>&#x000a0;Corneal edema and decompensation, however, are higher in the CS subtype.&#x000a0;Depending on the severity of endothelial disease in any subtype of ICE, patients may be approached differently during intraocular surgeries such as cataract extraction; patients may undergo combined DSAEK and cataract extraction to address their corneal endothelial disease.<xref ref-type="bibr" rid="article-141745.r51">[51]</xref></p>
      </sec>
      <sec id="article-141745.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Although ICE is a rare disorder, patients with unilateral corneal edema, iridic changes, vision changes, or the development of glaucoma need to be carefully evaluated for this condition, particularly if the changes occur in a&#x000a0;woman between 20 and 50 years of age.<xref ref-type="bibr" rid="article-141745.r1">[1]</xref><xref ref-type="bibr" rid="article-141745.r6">[6]</xref>&#x000a0;A thorough evaluation and prompt diagnosis&#x000a0;can prevent the development or worsening of corneal decompensation due to corneal edema or secondary glaucoma due to PAS.<xref ref-type="bibr" rid="article-141745.r1">[1]</xref>&#x000a0;Education&#x000a0;about ICE and its&#x000a0;variants and early diagnosis can help prevent the progression of this vision-threatening disease.</p>
      </sec>
      <sec id="article-141745.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Enhancing outcomes for&#x000a0;patients with ICE involves a comprehensive approach that addresses both the ocular manifestations and associated complications.&#x000a0;ICE is a rare but serious condition often overlooked or misdiagnosed in a clinical setting. Prompt diagnosis is crucial for patients with ICE, and regular eye examinations conducted by eye care professionals or primary care providers can help to identify the disease in its early stages. ICE should be considered in patients presenting with changes in the shape of the iris or visual acuity, corneal edema, or blurred vision, particularly if the patient is a woman between the ages of 20 and 50.<xref ref-type="bibr" rid="article-141745.r1">[1]</xref><xref ref-type="bibr" rid="article-141745.r5">[5]</xref></p>
        <p>Patients exhibiting symptoms suggestive of ICE should be referred to healthcare providers capable of performing comprehensive ophthalmic examinations, which may include slit-lamp examination, specular microscopy, and gonioscopy.<xref ref-type="bibr" rid="article-141745.r2">[2]</xref>&#x000a0;Timely intervention with medical or surgical treatment can help prevent or mitigate potential complications.&#x000a0;Collaboration among ophthalmologists, glaucoma specialists, corneal specialists, and other relevant healthcare professionals can provide comprehensive care for patients with ICES. This multidisciplinary approach ensures that all aspects of the condition are addressed effectively.<xref ref-type="bibr" rid="article-141745.r1">[1]</xref><xref ref-type="bibr" rid="article-141745.r5">[5]</xref></p>
        <p>Ensuring patients are educated about ICE, including its symptoms, available treatment options, and the significance of medication adherence and follow-up visits, is paramount. Providing support and addressing patient concerns can enhance their understanding and cooperation with the treatment plan, leading to better outcomes. The specific management plan should be tailored to each individual based on their unique circumstances and needs.&#x000a0;</p>
      </sec>
      <sec id="article-141745.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=141745&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=141745">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/eye-health/iridocorneal-endothelial-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=141745">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/141745/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=141745">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-141745.s16">
        <fig id="article-141745.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Iridocorneal Endothelial Syndrome: Corneal Endothelium Irregularities. Cross-sectional view of the cornea on slit-lamp biomicroscopy depicting corneal edema with typical "beaten bronze" or "hammered silver" appearance of the corneal endothelium. Contributed by Gustavo Espinoza, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="unnamed" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-141745.s17">
        <fig id="article-141745.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Iridocorneal Endothelial Syndrome: Essential Endothelial Syndrome. This image shows essential iris atrophy (or progressive essential iris atrophy), one of the 3 variants of iridocorneal endothelial syndrome. This variant has more iris changes like atrophic patches, heterochromia, corectopia, polycoria, and a peripheral hole compared to the other 2 variants. Contributed by Gustavo Espinoza, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="4" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-141745.s18">
        <fig id="article-141745.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Iridocorneal Endothelial Syndrome: Secondary Angle-Closure Glaucoma. Slit-lamp biomicroscopy image of the shallow anterior chamber of the eye in a patient with iridocorneal endothelial syndrome suggestive of secondary angle-closure glaucoma. Contributed by Gustavo Espinoza, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="2" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-141745.s19">
        <title>References</title>
        <ref id="article-141745.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Silva</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Najafi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Suwan</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Teekhasaenee</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ritch</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The iridocorneal endothelial syndrome.</article-title>
            <source>Surv Ophthalmol</source>
            <year>2018</year>
            <season>Sep-Oct</season>
            <volume>63</volume>
            <issue>5</issue>
            <fpage>665</fpage>
            <page-range>665-676</page-range>
            <pub-id pub-id-type="pmid">29331589</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sacchetti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mantelli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Marenco</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Macchi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ambrosio</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Rama</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and Management of Iridocorneal Endothelial Syndrome.</article-title>
            <source>Biomed Res Int</source>
            <year>2015</year>
            <volume>2015</volume>
            <fpage>763093</fpage>
            <pub-id pub-id-type="pmid">26451377</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Etiological mechanism of iridocorneal endothelial (ICE) syndrome may involve infection of herpes simplex virus (HSV) and integration of viral genes into human genome.</article-title>
            <source>Med Hypotheses</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>110</volume>
            <fpage>50</fpage>
            <page-range>50-52</page-range>
            <pub-id pub-id-type="pmid">29317068</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dubey</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mukhejee</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Iridocorneal Endothelial Syndrome with Coexisting Macular Edema and Neurosensory Detachment: An Unusual Case Report.</article-title>
            <source>J Curr Glaucoma Pract</source>
            <year>2021</year>
            <season>Sep-Dec</season>
            <volume>15</volume>
            <issue>3</issue>
            <fpage>149</fpage>
            <page-range>149-152</page-range>
            <pub-id pub-id-type="pmid">35173398</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Walkden</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Au</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Iridocorneal endothelial syndrome: clinical perspectives.</article-title>
            <source>Clin Ophthalmol</source>
            <year>2018</year>
            <volume>12</volume>
            <fpage>657</fpage>
            <page-range>657-664</page-range>
            <pub-id pub-id-type="pmid">29670326</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Srinivasan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sihota</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Bilateral iridocorneal endothelial syndrome in a young girl with Down's syndrome.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2009</year>
            <season>Jan-Feb</season>
            <volume>57</volume>
            <issue>1</issue>
            <fpage>61</fpage>
            <page-range>61-3</page-range>
            <pub-id pub-id-type="pmid">19075416</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Joyce</surname>
                <given-names>NC</given-names>
              </name>
            </person-group>
            <article-title>Proliferative capacity of corneal endothelial cells.</article-title>
            <source>Exp Eye Res</source>
            <year>2012</year>
            <month>Feb</month>
            <volume>95</volume>
            <issue>1</issue>
            <fpage>16</fpage>
            <page-range>16-23</page-range>
            <pub-id pub-id-type="pmid">21906590</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Dou</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Qi</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Duan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Dong</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>BN</given-names>
              </name>
              <name>
                <surname>Xie</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Heterogeneity of human corneal endothelium implicates lncRNA <italic>NEAT1</italic> in Fuchs endothelial corneal dystrophy.</article-title>
            <source>Mol Ther Nucleic Acids</source>
            <year>2022</year>
            <month>Mar</month>
            <day>08</day>
            <volume>27</volume>
            <fpage>880</fpage>
            <page-range>880-893</page-range>
            <pub-id pub-id-type="pmid">35141048</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Price</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Mehta</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Jurkunas</surname>
                <given-names>UV</given-names>
              </name>
              <name>
                <surname>Price</surname>
                <given-names>FW</given-names>
              </name>
            </person-group>
            <article-title>Corneal endothelial dysfunction: Evolving understanding and treatment options.</article-title>
            <source>Prog Retin Eye Res</source>
            <year>2021</year>
            <month>May</month>
            <volume>82</volume>
            <fpage>100904</fpage>
            <pub-id pub-id-type="pmid">32977001</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bahn</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Falls</surname>
                <given-names>HF</given-names>
              </name>
              <name>
                <surname>Varley</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Edelhauser</surname>
                <given-names>HF</given-names>
              </name>
              <name>
                <surname>Bourne</surname>
                <given-names>WM</given-names>
              </name>
            </person-group>
            <article-title>Classification of corneal endothelial disorders based on neural crest origin.</article-title>
            <source>Ophthalmology</source>
            <year>1984</year>
            <month>Jun</month>
            <volume>91</volume>
            <issue>6</issue>
            <fpage>558</fpage>
            <page-range>558-63</page-range>
            <pub-id pub-id-type="pmid">6462621</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Williams</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Bohnsack</surname>
                <given-names>BL</given-names>
              </name>
            </person-group>
            <article-title>The Ocular Neural Crest: Specification, Migration, and Then What?</article-title>
            <source>Front Cell Dev Biol</source>
            <year>2020</year>
            <volume>8</volume>
            <fpage>595896</fpage>
            <pub-id pub-id-type="pmid">33425902</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r12">
          <label>12</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Jat</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Peters Anomaly</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">35593847</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r13">
          <label>13</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Singh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Iridocorneal Dysgenesis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">36251848</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alkatan</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Al Dhaheri</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Al Harby</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Terminology of Peters' anomaly variants: Summary of histopathological findings in 6 corneas and detailed clinicopathological correlation in 2 cases.</article-title>
            <source>Saudi J Ophthalmol</source>
            <year>2019</year>
            <season>Jul-Sep</season>
            <volume>33</volume>
            <issue>3</issue>
            <fpage>277</fpage>
            <page-range>277-282</page-range>
            <pub-id pub-id-type="pmid">31686970</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Almarzouki</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Tayyib</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Khayat</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Alsulami</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Alzahrani</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Alkahtani</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Alghifees</surname>
                <given-names>LS</given-names>
              </name>
            </person-group>
            <article-title>Peters Anomaly in Twins: A Case Report of a Rare Incident with Novel Comorbidities.</article-title>
            <source>Case Rep Ophthalmol</source>
            <year>2016</year>
            <season>Sep-Dec</season>
            <volume>7</volume>
            <issue>3</issue>
            <fpage>186</fpage>
            <page-range>186-192</page-range>
            <pub-id pub-id-type="pmid">27843434</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ni</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>A novel histopathologic finding in the Descemet's membrane of a patient with Peters Anomaly: a case-report and literature review.</article-title>
            <source>BMC Ophthalmol</source>
            <year>2015</year>
            <month>Oct</month>
            <day>23</day>
            <volume>15</volume>
            <fpage>139</fpage>
            <pub-id pub-id-type="pmid">26496717</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sault</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Sheridan</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Peters' anomaly.</article-title>
            <source>Ophthalmol Eye Dis</source>
            <year>2013</year>
            <volume>5</volume>
            <fpage>1</fpage>
            <page-range>1-3</page-range>
            <pub-id pub-id-type="pmid">23650461</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elhalis</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Azizi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Jurkunas</surname>
                <given-names>UV</given-names>
              </name>
            </person-group>
            <article-title>Fuchs endothelial corneal dystrophy.</article-title>
            <source>Ocul Surf</source>
            <year>2010</year>
            <month>Oct</month>
            <volume>8</volume>
            <issue>4</issue>
            <fpage>173</fpage>
            <page-range>173-84</page-range>
            <pub-id pub-id-type="pmid">20964980</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Campbell</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>TR</given-names>
              </name>
            </person-group>
            <article-title>The corneal endothelium and the spectrum of essential iris atrophy.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1978</year>
            <month>Sep</month>
            <volume>86</volume>
            <issue>3</issue>
            <fpage>317</fpage>
            <page-range>317-24</page-range>
            <pub-id pub-id-type="pmid">717494</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r20">
          <label>20</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Sridhar</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Iris Ectropion Syndrome</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">35593818</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Marshall</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Kirkness</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Corneal endothelial cell abnormalities in an early stage of the iridocorneal endothelial syndrome.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1994</year>
            <month>Aug</month>
            <volume>78</volume>
            <issue>8</issue>
            <fpage>624</fpage>
            <page-range>624-31</page-range>
            <pub-id pub-id-type="pmid">7918291</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alvarado</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Underwood</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Green</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Hwang</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>O'Day</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Detection of herpes simplex viral DNA in the iridocorneal endothelial syndrome.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1994</year>
            <month>Dec</month>
            <volume>112</volume>
            <issue>12</issue>
            <fpage>1601</fpage>
            <page-range>1601-9</page-range>
            <pub-id pub-id-type="pmid">7993217</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Herde</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>[Iridocorneal endothelial syndrome (ICE-S): classification, clinical picture, diagnosis].</article-title>
            <source>Klin Monbl Augenheilkd</source>
            <year>2005</year>
            <month>Oct</month>
            <volume>222</volume>
            <issue>10</issue>
            <fpage>797</fpage>
            <page-range>797-801</page-range>
            <pub-id pub-id-type="pmid">16240272</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ye</surname>
                <given-names>WQ</given-names>
              </name>
              <name>
                <surname>Deng</surname>
                <given-names>YX</given-names>
              </name>
              <name>
                <surname>Zuo</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>HO</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Zheng</surname>
                <given-names>QX</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>YB</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>[Clinical characteristics of 114 patients with iridocorneal endothelial syndrome].</article-title>
            <source>Zhonghua Yan Ke Za Zhi</source>
            <year>2022</year>
            <month>Jan</month>
            <day>11</day>
            <volume>58</volume>
            <issue>1</issue>
            <fpage>35</fpage>
            <page-range>35-40</page-range>
            <pub-id pub-id-type="pmid">34979791</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Malhotra</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Seth</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>Pandav</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Kaushik</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Raj</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dhingra</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Iridocorneal endothelial syndrome: Evaluation of patient demographics and endothelial morphology by <italic>in vivo</italic> confocal microscopy in an Indian cohort.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2019</year>
            <month>May</month>
            <volume>67</volume>
            <issue>5</issue>
            <fpage>604</fpage>
            <page-range>604-610</page-range>
            <pub-id pub-id-type="pmid">31007217</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Le</surname>
                <given-names>QH</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>XH</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>In-vivo confocal microscopy of iridocorneal endothelial syndrome.</article-title>
            <source>Int Ophthalmol</source>
            <year>2009</year>
            <month>Feb</month>
            <volume>29</volume>
            <issue>1</issue>
            <fpage>11</fpage>
            <page-range>11-8</page-range>
            <pub-id pub-id-type="pmid">18297250</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feizi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Corneal endothelial cell dysfunction: etiologies and management.</article-title>
            <source>Ther Adv Ophthalmol</source>
            <year>2018</year>
            <season>Jan-Dec</season>
            <volume>10</volume>
            <fpage>2515841418815802</fpage>
            <pub-id pub-id-type="pmid">30560230</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Deng</surname>
                <given-names>SX</given-names>
              </name>
            </person-group>
            <article-title>Corneal Endothelial Decompensation.</article-title>
            <source>Klin Monbl Augenheilkd</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>237</volume>
            <issue>6</issue>
            <fpage>745</fpage>
            <page-range>745-753</page-range>
            <pub-id pub-id-type="pmid">32516831</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chandran</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Mandal</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Choudhari</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Garudadri</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Senthil</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Glaucoma associated with iridocorneal endothelial syndrome in 203 Indian subjects.</article-title>
            <source>PLoS One</source>
            <year>2017</year>
            <volume>12</volume>
            <issue>3</issue>
            <fpage>e0171884</fpage>
            <pub-id pub-id-type="pmid">28282413</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jonas</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Aung</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bourne</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Bron</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Ritch</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Panda-Jonas</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Glaucoma.</article-title>
            <source>Lancet</source>
            <year>2017</year>
            <month>Nov</month>
            <day>11</day>
            <volume>390</volume>
            <issue>10108</issue>
            <fpage>2183</fpage>
            <page-range>2183-2193</page-range>
            <pub-id pub-id-type="pmid">28577860</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dada</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Gadia</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ichhpujani</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bali</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Bhartiya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Panda</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Ultrasound biomicroscopy in glaucoma.</article-title>
            <source>Surv Ophthalmol</source>
            <year>2011</year>
            <season>Sep-Oct</season>
            <volume>56</volume>
            <issue>5</issue>
            <fpage>433</fpage>
            <page-range>433-50</page-range>
            <pub-id pub-id-type="pmid">21783220</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r32">
          <label>32</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Ruia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Humphrey Visual Field</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">36256759</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r33">
          <label>33</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Dietze</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Blair</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Zeppieri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Havens</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <chapter-title>Glaucoma</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>3</month>
            <day>16</day>
            <pub-id pub-id-type="pmid">30855805</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dong</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Ouyang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ji</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Xie</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hou</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Comparison of Descemet Membrane Endothelial Keratoplasty for Iridocorneal Endothelial Syndrome and Fuchs Endothelial Dystrophy.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2021</year>
            <month>Jun</month>
            <volume>226</volume>
            <fpage>76</fpage>
            <page-range>76-82</page-range>
            <pub-id pub-id-type="pmid">33556383</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Phillips</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Goins</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Greiner</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Alward</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Kwon</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Wagoner</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Boston Type 1 Keratoprosthesis for Iridocorneal Endothelial Syndromes.</article-title>
            <source>Cornea</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>34</volume>
            <issue>11</issue>
            <fpage>1383</fpage>
            <page-range>1383-6</page-range>
            <pub-id pub-id-type="pmid">26398156</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wand</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gilbert</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Liesegang</surname>
                <given-names>TJ</given-names>
              </name>
            </person-group>
            <article-title>Latanoprost and herpes simplex keratitis.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1999</year>
            <month>May</month>
            <volume>127</volume>
            <issue>5</issue>
            <fpage>602</fpage>
            <page-range>602-4</page-range>
            <pub-id pub-id-type="pmid">10334356</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Laganowski</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Kerr Muir</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Hitchings</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Glaucoma and the iridocorneal endothelial syndrome.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1992</year>
            <month>Mar</month>
            <volume>110</volume>
            <issue>3</issue>
            <fpage>346</fpage>
            <page-range>346-50</page-range>
            <pub-id pub-id-type="pmid">1543451</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ito</surname>
                <given-names>YA</given-names>
              </name>
              <name>
                <surname>Walter</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Genomics and anterior segment dysgenesis: a review.</article-title>
            <source>Clin Exp Ophthalmol</source>
            <year>2014</year>
            <season>Jan-Feb</season>
            <volume>42</volume>
            <issue>1</issue>
            <fpage>13</fpage>
            <page-range>13-24</page-range>
            <pub-id pub-id-type="pmid">24433355</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r39">
          <label>39</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Mahabadi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Zeppieri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Open Angle Glaucoma</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>3</month>
            <day>7</day>
            <pub-id pub-id-type="pmid">28722917</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r40">
          <label>40</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Zeppieri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Pigment Dispersion Glaucoma</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">35593820</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Denis</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>[Iridocorneal endothelial syndrome and glaucoma].</article-title>
            <source>J Fr Ophtalmol</source>
            <year>2007</year>
            <month>Feb</month>
            <volume>30</volume>
            <issue>2</issue>
            <fpage>189</fpage>
            <page-range>189-95</page-range>
            <pub-id pub-id-type="pmid">17318107</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kidd</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hetherington</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Magee</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Surgical results in iridocorneal endothelial syndrome.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1988</year>
            <month>Feb</month>
            <volume>106</volume>
            <issue>2</issue>
            <fpage>199</fpage>
            <page-range>199-201</page-range>
            <pub-id pub-id-type="pmid">3341974</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Doe</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Budenz</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Gedde</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Imami</surname>
                <given-names>NR</given-names>
              </name>
            </person-group>
            <article-title>Long-term surgical outcomes of patients with glaucoma secondary to the iridocorneal endothelial syndrome.</article-title>
            <source>Ophthalmology</source>
            <year>2001</year>
            <month>Oct</month>
            <volume>108</volume>
            <issue>10</issue>
            <fpage>1789</fpage>
            <page-range>1789-95</page-range>
            <pub-id pub-id-type="pmid">11581050</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ali&#x000f3;</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Rodriguez</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Toffaha</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Pi&#x000f1;ero</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Moreno</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>Femtosecond-assisted keratopigmentation for functional and cosmetic restoration in essential iris atrophy.</article-title>
            <source>J Cataract Refract Surg</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>37</volume>
            <issue>10</issue>
            <fpage>1744</fpage>
            <page-range>1744-7</page-range>
            <pub-id pub-id-type="pmid">21865008</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khng</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Snyder</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Iris reconstruction with a multipiece endocapsular prosthesis in iridocorneal endothelial syndrome.</article-title>
            <source>J Cataract Refract Surg</source>
            <year>2005</year>
            <month>Nov</month>
            <volume>31</volume>
            <issue>11</issue>
            <fpage>2051</fpage>
            <page-range>2051-4</page-range>
            <pub-id pub-id-type="pmid">16412914</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Agarwal</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Anterior segment optical coherence tomography of iridoschisis.</article-title>
            <source>BMJ Case Rep</source>
            <year>2021</year>
            <month>Oct</month>
            <day>05</day>
            <volume>14</volume>
            <issue>10</issue>
            <pub-id pub-id-type="pmid">34610957</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r47">
          <label>47</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Salini</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <chapter-title>Aniridia</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">30844160</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hingorani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hanson</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>van Heyningen</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Aniridia.</article-title>
            <source>Eur J Hum Genet</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>20</volume>
            <issue>10</issue>
            <fpage>1011</fpage>
            <page-range>1011-7</page-range>
            <pub-id pub-id-type="pmid">22692063</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sorkin</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Einan-Lifshitz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Boutin</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Showail</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Borovik</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Rootman</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Descemet membrane endothelial keratoplasty in iridocorneal endothelial syndrome and posterior polymorphous corneal dystrophy.</article-title>
            <source>Can J Ophthalmol</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>54</volume>
            <issue>2</issue>
            <fpage>190</fpage>
            <page-range>190-195</page-range>
            <pub-id pub-id-type="pmid">30975342</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rotenberg</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Downward</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Curnow</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Larkin</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Tuft</surname>
                <given-names>SJ</given-names>
              </name>
              <collab>National Health Service Blood and Ocular Tissue Advisory Group and Contributing Ophthalmologists (OTAG Study 27)</collab>
            </person-group>
            <article-title>Graft Survival After Penetrating and Endothelial Keratoplasty in Iridocorneal Endothelial Syndrome.</article-title>
            <source>Cornea</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>39</volume>
            <issue>1</issue>
            <fpage>18</fpage>
            <page-range>18-22</page-range>
            <pub-id pub-id-type="pmid">31335531</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141745.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garc&#x000ed;a Caride</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cui&#x000f1;a Sardi&#x000f1;a</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Perucho Gonz&#x000e1;lez</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Combined cataract surgery and lamellar endothelial keratoplasty in iridocorneal endothelial syndrome.</article-title>
            <source>Arch Soc Esp Oftalmol (Engl Ed)</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>95</volume>
            <issue>9</issue>
            <fpage>451</fpage>
            <page-range>451-454</page-range>
            <pub-id pub-id-type="pmid">32595005</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
